References
- Weatherall DJ, Clegg JB. The thalassaemia syndromes. Oxford, UK: John Wiley & Sons; 2008
- Marengo-Rowe AG. The thalassemias and related disorders. Proc (Bayl Univ Med Cent) 2007;20:27–31
- Tripatara A, Jetsrisuparb A, Teeratakulpisarn J, Kuaha K. Haemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease. Thromb Res 2007;120:805–10
- Borgna Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicentric study. Acta Haematol 1998;99:76–9
- Cappellini MD, Poggiali E, Taher AT, Musallam KM. Hypercoagulability in β-thalassemia: a status quo. Expert Rev Hematol 2012;5:505–11
- Mussallam KM, Taher AT. Thrombosis in thalassemia: why are we also concerned? Hemoglobin 2011;35:503–10
- Cappellini D, Motta I, Musallam KM, Taher AT. Redefining thalassemia as a hypercoagulable state. Ann N Y Acad Sci 2010;1202:231–6
- Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002;99:36–43
- Taher AT, Musallam KM, Karimi M, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010;115:1886–92
- Maakaron J, Cappellini MD, Taher AT. An update on thalassemia intermedia. J Med Liban 2013;61:175–82
- Taher AT, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev 2008;22:283–92
- Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187–93
- Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev 2008;6:158–69
- Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010;5:11. doi: 10.1186/1750-1172-5-11
- Filosa A, Di Maio S, Aloj G, Acampora C. Longitudinal study on thyroid function in patients with thalassemia major. J Pediatr Endocrinol Metab 2006;19:1397–404
- Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005;353:1135–46
- Origa R, Fiumana E, Gamberini MR, et al. Osteoporosis in beta-thalassemia: clinical and genetic aspects. Ann N Y Acad Sci 2005;1054:451–6
- Gurevitch O, Slavin S. The hematological etiology of osteoporosis. Med Hypotheses 2006;67:729–35
- Scacchi M, Danesi L, Cattaneo A, et al. Bone demineralization in adult thalassaemic patients. Contribution of growth hormone and insulin-like growth factor-I at different skeletal sites. Clin Endocrinol (Oxf) 2008;69:202–7
- Lasco A, Morabito N, Gaudio A, et al. Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis. J Endocrinol Invest 2002;25:338–44
- Tolis G, Papandreou A, Karydis I. Amenorrhea in beta-homozygous thalassemia major. Ann N Y Acad Sci 1997;816:274–9
- De Sanctis. Growth and puberty and its management in thalassaemia. Horm Res 2002;58:72–9
- Al-Rimawi HS, Jallad MF, Amarin ZO, Obeidat BR. Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major. Int J Gynaecol Obstet 2005;90:44–7
- De Sanctis V, Vullo C, Katz M, et al. Hypothalamic-pituitary-gonadal axis in thalassaemic patients with secondary amenorrhea. Obstet Gynecol 1988;72:643–7
- Chatterjee R, Katz M, Cox TF, Porter JB. Prospective study of the hypothalamic-pituitary axis in thalassaemic patients who developed secondary amenorrhea. Clin Endocrinol (Oxf) 1993;39:287–96
- Protonotariou AA, Tolis GJ. Reproductive health in female patients with beta-thalassaemia major. Ann N Y Acad Sci 2000;900:119–24
- Allais G, Castagnoli Gabellari I, De Lorenzo C, et al. Menstrual migraine: clinical and therapeutical aspects. Expert Rev Neurother 2007;7:1105–20
- Picardo E, Mitidieri M, Minniti E, et al. The first case of breast cancer in thalassemic patient: case report and review of literature. Gynecol Endocrinol 2015;31:345–8
- Greif JM. Mammographic screening for breast cancer: an invited review of the benefits and costs. Breast 2010;19:268–72
- Zacharski L. Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008;100:996–1002
- Origa R, Piga A, Quarta G, et al. Pregnancy and beta-thalassemia: an Italian multicenter experience. Haematologica 2010;95:376–81
- Kyriakou A, Skordis N. Thalassemia and aberrations of growth and puberty. Mediterr J Hematol Infect Dis 2009;1:e2009003
- De Sanctis V, Soliman AT, Elsedfy H, et al. Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. Pediatr Endocrinol Rev 2013;11:167–80
- Dwyer J, Wood C, McNamara J, et al. Abnormalities in the immune system of children with beta-thalassaemia major. Clin Exp Immunol 1987;68:621–9
- Ricerca BM, Di Girolamo A, Rund D. Infection in thalassemia and hemoglobinopathies: therapy related complications. Mediterr J Hematol Infect Dis 2009;1:e2009028
- Roussou P, Tsagarakis NJ, Kountouras D, et al. Beta thalassemia major and female fertility: the role of iron and iron-induced oxidative stress. Anemia 2013;2013:617204
- Skordis N, Petrikkos L, Toumba M, et al. Update on fertility in thalassemia major. Pediatr Endocrinol Rev 2004;2:296–302
- Aessopos A, Karabatsos F, Farmakis D, et al. Pregnancy in patients with well-treated beta-thalassemia: outcome for mothers and newborn infants. Am J Obstet Gynecol 1999;180:360–5
- Leung TY, Lao TT. Thalassemia in pregnancy. Best Pract Res Clin Obstet Gynaecol 2012;26:37–51
- Fauser BC, Serour GI. Introduction: optimal in vitro fertilization in 2020: the global perspective. Fertil Steril 2013;100:297–8
- Kamphuis EI, Bhattacharya S, van der Veen F, et al. Are we overusing IVF? BMJ 2014;348:252–6
- Li Y, Altarescu G, Renbaum P, et al. Non-invasive prenatal diagnosis using cell-free fetal DNA in maternal plasma from PGD pregnancies. Reprod Biomed Online 2009;19:714–20
- Papasavva T, van Ijcken WF, Kockx CE, et al. Next generation sequencing of SNPs for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia. Eur J Hum Genet 2013;21:1403–10
- Xiong L, Barrett AN, Hua R, et al. Non-invasive prenatal diagnostic testing for β-thalassaemia using cell-free fetal DNA and next generation sequencing. Prenat Diagn 2015;35:258–65
- Liu S, Chen L, Zhang X, et al. Primer-introduced restriction analysis polymerase chain reaction method for non-invasive prenatal testing of β-thalassemia. Hemoglobin 2015;39:18–23